HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure

Paul L. Reiter; Annie Laurie McRee; Sami L. Gottlieb; Noel T. Brewer

doi:10.1016/j.vaccine.2010.06.114

HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure

Paul L. Reiter, Annie Laurie McRee, Sami L. Gottlieb, Noel T. Brewer

Research output: Contribution to journal › Article › peer-review

56 Scopus citations

Abstract

We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 months after approval of HPV vaccine for males, we surveyed a national sample of mothers with sons aged 9-18 (n=406). More mothers were definitely or probably willing to get their sons HPV vaccine if the vaccine were free (47%) than if it cost $ 400 out of pocket (11%). The importance of HPV vaccine possibly protecting their sons' future female partners from HPV-related disease was the strongest correlate of willingness. These findings are important to increasing acceptability to parents of HPV vaccine for their sons.

Original language	English (US)
Pages (from-to)	6292-6297
Number of pages	6
Journal	Vaccine
Volume	28
Issue number	38
DOIs	https://doi.org/10.1016/j.vaccine.2010.06.114
State	Published - Aug 2010

Bibliographical note

Funding Information:
This study was primarily funded by a grant from the Centers for Disease Control and Prevention (CDC, 02577-10 ) with additional support for project staff from the American Cancer Society (MSRG-06-259-01-CPPB) and the Cancer Control Education Program at Lineberger Comprehensive Cancer Center (R25 CA57726 ). Members of the CDC were involved in conducting the study and in preparing and submitting this article. None of the other funding sources had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

Keywords

Acceptability
HPV vaccine
Males

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.

Publisher link

10.1016/j.vaccine.2010.06.114

Find It

Find It at U of M Libraries

Cite this

@article{e0bf8180759f45b98b4074904093a7fa,

title = "HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure",

abstract = "We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 months after approval of HPV vaccine for males, we surveyed a national sample of mothers with sons aged 9-18 (n=406). More mothers were definitely or probably willing to get their sons HPV vaccine if the vaccine were free (47%) than if it cost $ 400 out of pocket (11%). The importance of HPV vaccine possibly protecting their sons' future female partners from HPV-related disease was the strongest correlate of willingness. These findings are important to increasing acceptability to parents of HPV vaccine for their sons.",

keywords = "Acceptability, HPV vaccine, Males",

author = "Reiter, {Paul L.} and McRee, {Annie Laurie} and Gottlieb, {Sami L.} and Brewer, {Noel T.}",

note = "Funding Information: This study was primarily funded by a grant from the Centers for Disease Control and Prevention (CDC, 02577-10 ) with additional support for project staff from the American Cancer Society (MSRG-06-259-01-CPPB) and the Cancer Control Education Program at Lineberger Comprehensive Cancer Center (R25 CA57726 ). Members of the CDC were involved in conducting the study and in preparing and submitting this article. None of the other funding sources had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. ",

year = "2010",

month = aug,

doi = "10.1016/j.vaccine.2010.06.114",

language = "English (US)",

volume = "28",

pages = "6292--6297",

journal = "Vaccine",

issn = "0264-410X",

publisher = "Elsevier Ltd",

number = "38",

}

TY - JOUR

T1 - HPV vaccine for adolescent males

T2 - Acceptability to parents post-vaccine licensure

AU - Reiter, Paul L.

AU - McRee, Annie Laurie

AU - Gottlieb, Sami L.

AU - Brewer, Noel T.

N1 - Funding Information: This study was primarily funded by a grant from the Centers for Disease Control and Prevention (CDC, 02577-10 ) with additional support for project staff from the American Cancer Society (MSRG-06-259-01-CPPB) and the Cancer Control Education Program at Lineberger Comprehensive Cancer Center (R25 CA57726 ). Members of the CDC were involved in conducting the study and in preparing and submitting this article. None of the other funding sources had a role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.

PY - 2010/8

Y1 - 2010/8

N2 - We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 months after approval of HPV vaccine for males, we surveyed a national sample of mothers with sons aged 9-18 (n=406). More mothers were definitely or probably willing to get their sons HPV vaccine if the vaccine were free (47%) than if it cost $ 400 out of pocket (11%). The importance of HPV vaccine possibly protecting their sons' future female partners from HPV-related disease was the strongest correlate of willingness. These findings are important to increasing acceptability to parents of HPV vaccine for their sons.

AB - We examined mothers' willingness to get their adolescent sons HPV vaccine. In December 2009, 2 months after approval of HPV vaccine for males, we surveyed a national sample of mothers with sons aged 9-18 (n=406). More mothers were definitely or probably willing to get their sons HPV vaccine if the vaccine were free (47%) than if it cost $ 400 out of pocket (11%). The importance of HPV vaccine possibly protecting their sons' future female partners from HPV-related disease was the strongest correlate of willingness. These findings are important to increasing acceptability to parents of HPV vaccine for their sons.

KW - Acceptability

KW - HPV vaccine

KW - Males

UR - http://www.scopus.com/inward/record.url?scp=77955660811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955660811&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2010.06.114

DO - 10.1016/j.vaccine.2010.06.114

M3 - Article

C2 - 20637770

AN - SCOPUS:77955660811

SN - 0264-410X

VL - 28

SP - 6292

EP - 6297

JO - Vaccine

JF - Vaccine

IS - 38

ER -

HPV vaccine for adolescent males: Acceptability to parents post-vaccine licensure

Abstract

Bibliographical note

Keywords

PubMed: MeSH publication types

Publisher link

Find It

Other files and links

Fingerprint

Cite this